Navigation Links
Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences
Date:10/26/2010

ATLANTA, Oct. 26 /PRNewswire-FirstCall/ --Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's largest provider of home health and hospice services, announced today that it will present at the Oppenheimer 21st Annual Healthcare Conference in New York at 2:10 p.m. ET on Tuesday, November 2, 2010 and the Credit Suisse 2010 Healthcare Conference in Phoenix, AZ at 1:30 p.m. MT (3:30 p.m. ET) on Wednesday, November 10, 2010.

The presentations will be available to the public via live audio webcasts, which may be accessed by visiting http://investors.gentiva.com/events.cfm. Visitors to this site will also be able to request advance notifications of these or other upcoming Gentiva events.

Gentiva executives will give attendees an overview of the Company's operations and strategic priorities, and review opportunities for growth as the United States home health and hospice industries provide more services to an aging population.

About Gentiva Health Services, Inc.Gentiva Health Services, Inc. is the nation's largest provider of home health and hospice services based on revenue, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. In August 2010, Gentiva acquired Odyssey HealthCare, Inc., one of the leading providers of hospice care in the United States. GTIV-G

Forward-Looking StatementCertain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of recently passed healthcare reform legislation and its subsequent implementation through governmental regulations; changes in Medicare, Medicaid and commercial payer reimbursement levels; the outcome of any inquiries into the Company's operations and business practices by governmental authorities; the Company's ability to effectively integrate Odyssey's operations and those of other acquisitions we may make, as well as the ability to achieve expected synergies and efficiencies within expected time frames; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010, as supplemented in the Company's quarterly report on Form 10-Q for the second quarter ended July 4, 2010.Financial and Investor Contact:Eric Slusser 770-951-6101eric.slusser@gentiva.comor John Mongelli770-221-6700john.mongelli@gentiva.comMedia Contact:Scott CianciulliBrainerd Communicators212-986-6667cianciulli@braincomm.com
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies
2. InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference
3. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
4. Frost & Sullivan Recognizes Visage Imaging, Inc. for its Medical Imaging Informatics in Healthcare Innovation
5. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
6. PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum
7. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
8. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
9. As Cholera Outbreak Spreads, World Vision Deploys Teams to Distribute Emergency Health Supplies, Focus on Preventative Measures
10. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
11. Endo to Present at the Oppenheimer Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... , April 18, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a CAGR ... Global Arthroscopy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017 /PRNewswire/ ... results of collaboration started in 2016, in which ... "Artificial Brain SOINN". The companies achieved initial results ... ultrasound solution by Artificial Brain SOINN. The results ... Tokyo Big Sight, April 19-21, at booths 4505 ...
Breaking Medicine Technology:
(Date:4/25/2017)... Marietta, GA (PRWEB) , ... April 25, 2017 ... ... implant and instrument solutions, announces the continuation of its strategic partnership with and ... surgeons in developing nations in the safe and effective management of complex spine ...
(Date:4/24/2017)... WASHINGTON, DC (PRWEB) , ... April 24, 2017 , ... ... was recognized during ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, ... the Santana Telehealth Project for using telemedicine to improve the lives of the poor ...
(Date:4/24/2017)... Antonio, TX (PRWEB) , ... April 24, 2017 , ... ... by the glitterati, those unreal icons inhabiting the rarified air of pop and film ... the paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from ...
(Date:4/24/2017)... ... 24, 2017 , ... Veteran Theresa James awoke to the sound of her ... In “Healing Tears,” James depicts every parent’s worst nightmare, when her three children were ... conversations and situations throughout my divorce,” James said. “After the death of my children, ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South African company ... available for purchase on RevNutrition.com, a popular website specializing in sales of nutritional products. ... in ancient India and Siam. It spread across Asia and Africa quickly, and today ...
Breaking Medicine News(10 mins):